Amgen (AMGN) volatility elevated at 38 into denosumab data
Tweet Send to a Friend
Amgen (Nasdaq: AMGN) closed at $51.30. Phase three data of denosumab for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
